TITLE

Anticholinergic drugs: response of parkinsonism not responsive to levodopa

AUTHOR(S)
Yamada, H.; Momose, T.; Okada, M.; Kuroiwa, Y.
PUB. DATE
January 2002
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Jan2002, p111
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66345913

 

Related Articles

  • Drug treatment of Parkinson's disease. Quinn, Niall // BMJ: British Medical Journal (International Edition);3/4/95, Vol. 310 Issue 6979, p575 

    Focuses on drugs available for treating Parkinson's disease. Anticholinergics; Amantadine; Levodopa; Dopamine agonists; Selegiline; Catechol O-methyl transferase.

  • Levodopa: long-term impact on Parkinson's disease.  // British Medical Journal (Clinical Research Edition);2/7/1981, Vol. 282 Issue 6262, p417 

    Examines the effect of levodopa on Parkinson's disease. Application of belladonna alkaloids or synthetic anticholinergic drugs; Changes in the characteristics of the patients brain; Depletion of cholinergic neurons in Alzheimer's dementia.

  • Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Lees, A.J. // BMJ: British Medical Journal (International Edition);8/21/93, Vol. 307 Issue 6902, p469 

    Compares the therapeutic effects of levodopa, selegiline and bromocriptine for the treatment of Parkinson's disease in Great Britain. Baseline characteristics of the three drugs; Adverse reactions of levodopa and selegiline; Therapeutic response of bromocriptine.

  • Delayed early morning turn "ON" in response to a single dose of levodopa in advanced Parkinson's disease: pharmacokinetics should be considered. Chciná, P.; Kuntsmann, C.; Reyes-Parada, M.; Sáez-Briones, P. // Journal of Neurology, Neurosurgery & Psychiatry;Dec2004, Vol. 75 Issue 12, p1782 

    Presents a letter to the editor on response to a single dose of levodopa in advanced Parkinson's disease.

  • Levodopa and the Progression of Parkinson's Disease. Walton-Hadlock, Janice L. // New England Journal of Medicine;3/31/2005, Vol. 352 Issue 13, p1386 

    A letter to the editor is presented in response to a study on levodopa and the progression of Parkinson's Disease by the Parkinson Study Group in the December 9, 2004 issue.

  • Alternatives to levodopa.  // British Medical Journal;5/15/1976, Vol. 1 Issue 6019, p1169 

    Focuses on the efficacy of levodopa for treating Parkinson's disease in Great Britain. Response of the patients to the treatment; Impact of the severe depletion of striatal dopa decarboxylase on the therapeutic effect of levodopa; Usefulness of dopamine agonists in conditions associated with...

  • Levodopa/carbidopa/valproic acid.  // Reactions Weekly;8/10/2013, Issue 1465, p25 

    An abstract of the article "Valproic acid-induced parkinsonism: Levodopa responsiveness with dyskinesia," by M. Silver and colleagues is presented.

  • Levodopa.  // Reactions Weekly;May2014, Vol. 1503 Issue 1, p26 

    An abstract of the article "Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients," by M. Politis and colleagues is presented.

  • Selegiline Delays Progression of Early Parkinson's. Raub, William // JAMA: Journal of the American Medical Association;1/5/90, Vol. 263 Issue 1, p21 

    Announces the approval of the monamine oxidase inhibitor selegiline by the U.S. Food and Drug Administration. Role of selegiline as an adjunctive treatment; Use for patients with Parkinson's disease that exhibit deterioration in response quality to levodopa and carbidopa therapy; Design of...

  • Bladder and bowel dysfunction in Parkinson’s disease. Sakakibara, R.; Uchiyama, T.; Yamanishi, T.; Shirai, K.; Hattori, T. // Journal of Neural Transmission;Mar2008, Vol. 115 Issue 3, p443 

    Bladder dysfunction (urinary urgency/frequency) and bowel dysfunction (constipation) are common non-motor disorders in Parkinson’s disease (PD). In contrast to motor disorder, the pelvic autonomic dysfunction is often non-responsive to levodopa treatment. Brain pathology mostly accounts...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics